Skip to content

Arginine Plaque Metabolism Pilot Clinical Study

Arginine Plaque Metabolism Pilot Clinical Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06954779
Enrollment
20
Registered
2025-05-02
Start date
2024-07-24
Completion date
2024-09-20
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque, Dental

Keywords

saliva

Brief summary

Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.

Interventions

1000ppm fluoride

DRUGTOM's Superior Sensitivity Relief Toothpaste

fluoride free

Sponsors

Colgate Palmolive
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Signed Informed Consent Form. * Male and female subjects aged 18-70 years, inclusive. * Availability for the nine-week duration of the clinical research study. * Good general health based on the opinion of the study investigator * Good general health

Exclusion criteria

* Moderate and/or advanced periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study. * Five or more carious lesions requiring immediate care. * Concurrent participation in any other oral care clinical study or test panel. * Self-reported pregnant or lactating women. * Dental prophylaxis received in the past four weeks prior to baseline examinations * History of tobacco use-smoking, vaping and chewing tobacco * Presence of orthodontic bands, presence of partial removable dentures * Tumor(s) of the soft or hard tissues of the oral cavity * Use of antibiotics or stain inducing medications any time during the two month prior to entry into the study * Use of oral care products containing antimicrobials (Zn, Sn, CPC, triclosan, alcohol containing mouthwash, etc

Design outcomes

Primary

MeasureTime frameDescription
Plaque collectionbaseline, week 3, week 4, week 6, week 7, week 8, week 9Fasting plaque will be collected before and after a sucrose rinse for lactic acid analysis and ammonia production.The plaque pH of collected samples will also be measured to provide trend data.

Secondary

MeasureTime frameDescription
Saliva collectionweek 5 and week 9Differences in the arginine concentration in saliva pre- and post-brushing with treatment. Differences in microbiome composition and activity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026